Safety and tolerability of the dual PI3K/mTOR inhibitor LY3023414 in treatment of patients with advanced mesothelioma Meeting Abstract
| Authors: | Zauderer, M. G.; Hyman, D. M.; Alley, E. W.; Bendell, J. C.; Novello, S.; Bauer, T. M.; Hanauske, A. R.; Szpurka, A. M.; Kang, S.; Chatterjee, A.; Wacheck, V.; Brueck, P.; Varghese, A. M. |
| Abstract Title: | Safety and tolerability of the dual PI3K/mTOR inhibitor LY3023414 in treatment of patients with advanced mesothelioma |
| Meeting Title: | 109th Annual Meeting of the American Association for Cancer Research (AACR) |
| Journal Title: | Cancer Research |
| Volume: | 78 |
| Issue: | 13 Suppl. |
| Meeting Dates: | 2018 Apr 14-18 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2018-07-01 |
| Language: | English |
| ACCESSION: | WOS:000468818900019 |
| DOI: | 10.1158/1538-7445.Am2018-ct020 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: CT020 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
